Diagnostic tests to confirm severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and serology tests to confirm the presence of SARS-CoV-2 antibodies, whether or not medically necessary. For these covered services, the member's cost share amount is waived.